Individuals across the US have adapted to a largely isolated lifestyle due to COVID-19, and many do not expect to return to normalcy until a COVID-19 vaccine is developed. Even with a vaccine, challenges and questions, such as vaccine access and public trust, will remain top of mind. While efforts in vaccine development surge forward, research on treatments for the symptoms of COVID-19 holds promise for preventing disease and extending life for patients with COVID-19. Experts at the forefront of research and development will discuss current standings and projections for COVID-19 vaccines and therapies, and will address some of the most pressing questions around the future of R&D for COVID-19.

This session will incorporate live polling, presented by the Harris Poll. This interactive feature is available for registered participants only.